ES2132082T3 - Composiciones para cicatrizar heridas que contienen el factor de crecimiento fibroplasto y acido ascorbico. - Google Patents

Composiciones para cicatrizar heridas que contienen el factor de crecimiento fibroplasto y acido ascorbico.

Info

Publication number
ES2132082T3
ES2132082T3 ES91312105T ES91312105T ES2132082T3 ES 2132082 T3 ES2132082 T3 ES 2132082T3 ES 91312105 T ES91312105 T ES 91312105T ES 91312105 T ES91312105 T ES 91312105T ES 2132082 T3 ES2132082 T3 ES 2132082T3
Authority
ES
Spain
Prior art keywords
ascorbic acid
compositions
growth factor
healing wounds
wounds containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91312105T
Other languages
English (en)
Inventor
Jeffrey C Geesin
Joel S Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
Johnson and Johnson Consumer Products Inc
Johnson and Johnson Consumer Companies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Consumer Products Inc, Johnson and Johnson Consumer Companies LLC filed Critical Johnson and Johnson Consumer Products Inc
Application granted granted Critical
Publication of ES2132082T3 publication Critical patent/ES2132082T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA COMPOSICION PARA CURAR HERIDAS DE LA PRESENTE INVENCION CONSTA DE FGF PURIFICADO Y ACIDO ASCORBICO. UN METODO PARA CURAR UNA HERIDA EN UN PACIENTE CONSISTE EN APLICAR A LA HERIDA UNA CANTIDAD DEL PRODUCTO DE LA COMPOSICION DE LA PRESENTE INVENCION.
ES91312105T 1991-01-02 1991-12-31 Composiciones para cicatrizar heridas que contienen el factor de crecimiento fibroplasto y acido ascorbico. Expired - Lifetime ES2132082T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63684391A 1991-01-02 1991-01-02

Publications (1)

Publication Number Publication Date
ES2132082T3 true ES2132082T3 (es) 1999-08-16

Family

ID=24553567

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91312105T Expired - Lifetime ES2132082T3 (es) 1991-01-02 1991-12-31 Composiciones para cicatrizar heridas que contienen el factor de crecimiento fibroplasto y acido ascorbico.

Country Status (9)

Country Link
EP (1) EP0493985B1 (es)
JP (1) JPH0570365A (es)
AT (1) ATE181082T1 (es)
AU (1) AU9008691A (es)
CA (1) CA2058597C (es)
DE (1) DE69131318T2 (es)
ES (1) ES2132082T3 (es)
GR (1) GR1002610B (es)
SG (1) SG94684A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262111B1 (en) 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
WO1998052560A1 (en) 1997-05-21 1998-11-26 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US6524568B2 (en) 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
DK1091735T3 (da) * 1998-06-22 2008-03-25 Cytomedix Inc Forbedret beriget blodpladesårhelemiddel
DE19913427A1 (de) 1999-03-25 2000-09-28 Wella Ag Verwendung von reduzierenden Verbindungen zur Verstärkung und Strukturverbesserung von Keratin enthaltenden Materialien
US8188043B2 (en) * 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
DE60142341D1 (de) * 2000-08-10 2010-07-22 Santen Pharmaceutical Co Ltd Förderer der Hautwundheilung
DE10128818A1 (de) * 2001-06-15 2002-12-19 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus Ascorbinsäure und einem oder mehreren Biochinonen zur Herstellung angiogenetisch wirksamer topischer Zubereitungen
DE10128911A1 (de) * 2001-06-15 2002-12-19 Beiersdorf Ag Verwendung von Ascorbinsäure zur Herstellung angiogenetisch wirksamer topischer Zubereitungen
FR2828401B1 (fr) * 2001-08-10 2003-11-07 Oreal Composition cosmetique ou dermatologique comprenant une association entre l'igf1 et/ou un compose mimetique de l'igf1, et l'acide ascorbique et/ou au moins l'un de ses derives
BR0309890A (pt) 2002-05-09 2005-05-10 Medigenes Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
DE10355085A1 (de) * 2003-11-24 2005-06-23 Schure, Frank, Dr. Wundverband
CN115607506B (zh) * 2022-12-17 2023-04-28 朗肽生物制药股份有限公司 含重组人碱性成纤维细胞生长因子无水膏剂制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000198A1 (en) * 1987-07-07 1989-01-12 Biotechnology Research Associates, J.V. Recombinant fibroblast growth factors
ATE105868T1 (de) * 1985-09-12 1994-06-15 Scios Nova Inc Rekombinanter fibroblast-wachstumsfaktor.
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
DE68907066T2 (de) * 1988-01-29 1993-12-16 Sumitomo Pharma Verbesserte Formulierungen mit kontrollierter Abgabe.
US5057494A (en) * 1988-08-03 1991-10-15 Ethicon, Inc. Method for preventing tissue damage after an ischemic episode

Also Published As

Publication number Publication date
CA2058597C (en) 2002-07-23
AU9008691A (en) 1992-07-09
ATE181082T1 (de) 1999-06-15
DE69131318T2 (de) 1999-12-16
CA2058597A1 (en) 1992-07-03
EP0493985A1 (en) 1992-07-08
GR1002610B (el) 1997-02-20
DE69131318D1 (de) 1999-07-15
SG94684A1 (en) 2003-03-18
GR910100515A (el) 1992-12-30
EP0493985B1 (en) 1999-06-09
JPH0570365A (ja) 1993-03-23

Similar Documents

Publication Publication Date Title
ES2132082T3 (es) Composiciones para cicatrizar heridas que contienen el factor de crecimiento fibroplasto y acido ascorbico.
DE68917300D1 (de) Heilung von wunden.
BR9206433A (pt) Formulação e processo para tratar ferimentos.
ATE88899T1 (de) Wundheilung und knochenregeneration.
ATE196604T1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und - regenerierung
EP0190018A3 (en) Use of transforming growth factor to promote wound healing and composition therefor
ATE182072T1 (de) Salbe zur wundbehandlung
DE69007964D1 (de) Verwendung von Thrombospondin zur Beschleunigung der Wundheilung.
DE69029625D1 (de) Verwendung von Retinoiden zur Umkehr glucocorticoid-induzierter Hautatrophie
ATE156363T1 (de) Wundheilung
ATA4993A (de) Topische zusammensetzung zur beschleunigung der wundheilung
IL83956A (en) Compositions for promoting wound healing containing a serotonin-antagonist

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 493985

Country of ref document: ES